How to manage poor wound healing in patients with low testosterone levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Poor Wound Healing in Patients with Low Testosterone Levels

Testosterone replacement therapy is recommended for patients with confirmed low testosterone levels who exhibit poor wound healing, aiming for total testosterone levels in the middle tertile of the normal reference range (450-600 ng/dL). 1

Diagnostic Confirmation

  • Confirm testosterone deficiency with two separate morning total testosterone measurements below 300 ng/dL 1
  • Ensure symptoms consistent with testosterone deficiency are present (reduced energy, diminished physical performance, fatigue, depression, reduced motivation, poor concentration, impaired memory, reduced sex drive, erectile dysfunction) 1, 2
  • Evaluate for conditions that may cause secondary hypogonadism: obesity, diabetes, pituitary dysfunction, HIV/AIDS, chronic narcotic use, chronic corticosteroid use 1, 2

Relationship Between Testosterone and Wound Healing

  • Research shows conflicting effects of testosterone on wound healing:
    • Some studies indicate that endogenous testosterone may inhibit wound healing and promote inflammation 3, 4
    • Other research suggests supraphysiological testosterone supplementation can improve granulation tissue maturation through enhanced angiogenesis in early wound healing 5
    • In diabetic models, 5α-Dihydrotestosterone has shown positive effects on wound healing with improved collagen formation and antioxidant properties 6

Treatment Approach for Poor Wound Healing

  • For patients with confirmed low testosterone and poor wound healing:
    • Initiate testosterone replacement therapy to achieve total testosterone levels in the middle tertile of normal range (450-600 ng/dL) 1
    • Monitor wound healing progress regularly during testosterone therapy 2
    • Consider that the optimal testosterone level for wound healing may differ from standard replacement targets 6, 5

Lifestyle Modifications

  • Counsel patients regarding weight loss and increased physical activity, which can:
    • Increase endogenous testosterone levels 1, 2
    • Potentially improve wound healing independently 2
    • Reduce cardiovascular risk factors that may impair wound healing 1

Monitoring During Treatment

  • Monitor testosterone levels to ensure they reach the target range of 450-600 ng/dL 1
  • Assess wound healing progress regularly with documentation of wound size, appearance, and healing rate 7
  • Monitor for potential adverse effects of testosterone therapy:
    • Cardiovascular symptoms (chest pain, shortness of breath, dizziness) 1
    • Hemoglobin/hematocrit levels 8
    • PSA in men over 40 years 8

Important Considerations and Contraindications

  • Testosterone therapy should not be commenced for 3-6 months in patients with a history of cardiovascular events 1
  • Testosterone therapy should not be prescribed to men who are currently trying to conceive 1
  • Counsel patients that current evidence cannot definitively state whether testosterone therapy increases or decreases cardiovascular risk 1

Caution in Special Populations

  • In patients with in-situ prostate cancer or previously treated prostate cancer, testosterone therapy should be used with caution 1
  • For patients wishing to preserve fertility, consider alternative treatments to testosterone replacement 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypogonadism with Normal FSH and LH Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Regulatory roles of androgens in cutaneous wound healing.

Thrombosis and haemostasis, 2003

Research

Androgen receptor-mediated inhibition of cutaneous wound healing.

The Journal of clinical investigation, 2002

Guideline

Management of Low DHEA Sulfate Levels in Patients on Testosterone Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.